{
  "url": "https://openlegislation.uk/national-health-service-cross-border-healthcare-and-miscellaneous-amendments-etc-eu-exit-regulations-2019/regulation-9",
  "json_url": "https://openlegislation.uk/national-health-service-cross-border-healthcare-and-miscellaneous-amendments-etc-eu-exit-regulations-2019/regulation-9.json",
  "legislation": "uksi/2019/777",
  "legislation_title": "The National Health Service (Cross-Border Healthcare and Miscellaneous Amendments etc.) (EU Exit) Regulations 2019",
  "legislation_url": "https://openlegislation.uk/national-health-service-cross-border-healthcare-and-miscellaneous-amendments-etc-eu-exit-regulations-2019",
  "path": "regulation/9",
  "kind": "regulation",
  "number": "9",
  "heading": "The National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) Regulations 2004",
  "text": "(1) The National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) Regulations 2004 are amended as follows.\n(2) In Schedule 2 (drugs, medicines and other substances that may be ordered only in certain circumstances), in the entry in column 2 of the table that corresponds to the entry in column 1 relating to drugs for the treatment of erectile dysfunction—\n(a) for sub-paragraph (b) (including the “or” at the end) substitute—\n“(b) a man who is a national of an EEA State who—\n(i) immediately before IP completion day was entitled to treatment by virtue of Article 7(2) of Council Regulation 1612/68 as extended by the EEA Agreement or was entitled to treatment by virtue of any other enforceable EU right;\n(ii) has erectile dysfunction and was on 14th September 1998 receiving a course of treatment under a national health insurance system of an EEA State for that condition with any of the drugs listed in sub-paragraph (a); and\n(iii) immediately before IP completion day was receiving a course of treatment as part of the health service for the condition mentioned in paragraph (ii) of this sub-paragraph with any of the drugs listed in sub-paragraph (a); or”;\n(b) for sub-paragraph (c) (including the “or” at the end) substitute—\n“(c) a man who is not a national of an EEA State but who is the member of the family of such a national and who—\n(i) immediately before IP completion day had an enforceable EU right to be treated no less favourably than the national in the provision of medical treatment;\n(ii) has erectile dysfunction and was on 14th September 1998 receiving a course of treatment for that condition with any of the drugs listed in sub-paragraph (a); and\n(iii) immediately before IP completion day was receiving a course of treatment as part of the health service for the condition mentioned in paragraph (ii) of this sub-paragraph with any of the drugs listed in sub-paragraph (a); or”.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Reg. 9 substituted (31.12.2020 immediately before IP completion day) by The Reciprocal and Cross-Border Healthcare (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1348), regs. 1, 8"
    },
    {
      "type": "I",
      "label": "I1",
      "text": "Reg. 9 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(1)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2019/777/regulation/9",
    "retrieved_at": "2026-10-28T22:42:10.279956+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}